← Open Payments lookup

JOSHUA GOLDEN: Open Payments

NPI 1336200849 · ATTLEBORO, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,728 in 40 payments from 7 companies in 2025. Trend: 2023 $788 · 2024 $737 · 2025 $1,728

Food & beverage: $1,728
CompanyPaymentsAmount
ABBVIE INC.17$349
Neurocrine BioSciences, Inc.4$323
Axsome Therapeutics, Inc.7$277
Vanda Pharmaceuticals Inc.5$270
E.R. Squibb & Sons, L.L.C.3$256
Otsuka America Pharmaceutical, Inc.2$211
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$42

Products named: VRAYLAR, INGREZZA, Auvelity, FANAPT, COBENFY, REXULTI, CAPLYTA.

Industry payments across MA — which companies pay providers there.